4.6 Article

Stem cell donor HLA typing improves CPRA in kidney allocation

期刊

AMERICAN JOURNAL OF TRANSPLANTATION
卷 21, 期 1, 页码 138-147

出版社

ELSEVIER SCIENCE INC
DOI: 10.1111/ajt.16156

关键词

clinical research; practice; health services and outcomes research; histocompatibility; kidney transplantation; nephrology; organ allocation; organ procurement and allocation; Organ Procurement and Transplantation Network (OPTN); panel reactive antibody (PRA); sensitization; United Network for Organ Sharing (UNOS)

资金

  1. Smidt Heart Institute

向作者/读者索取更多资源

The study found that HLA data derived from stem cell donors can generate CPRA values comparable to those from deceased kidney donors, improving upon issues with the current reference panel and enhancing equity in kidney transplant allocation.
The Organ Procurement and Transplantation Network (OPTN) Kidney Allocation System provides a priority to sensitized candidates based on the calculated panel reactive antibody (CPRA) value. The human leukocyte antigen (HLA) haplotype reference panel used for calculation of the CPRA by the United Network for Organ Sharing (UNOS), the OPTN contractor, has limitations. We derived a novel panel from the National Marrow Donor Program HLA haplotype data set and compared the accuracy of CPRA values generated with this panel (NMDP-CPRA) to those generated from the UNOS panel (UNOS-CPRA), using predicted and actual deceased donor kidney offers for a cohort of 24 282 candidates. The overall accuracy for kidney offers was similar using NMDP-CPRA and UNOS-CPRA. Accuracy was slightly higher for NMDP-CPRA than UNOS-CPRA for candidates in several highly sensitized CPRA categories, with deviations in linkage disequilibrium for Caucasians and the smaller size of the UNOS panel as contributing factors. HLA data derived from stem cell donors yields CPRA values that are comparable to those derived from deceased kidney donors while improving upon several problems with the current reference panel. Consideration should be given to using stem cell donors as the reference panel for calculation of CPRA to improve equity in kidney transplant allocation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据